The 14.2-hour half-life of AFSTYLA allows the flexibility to dose 2 or 3 times a week, depending on your needs.
Half-life measures how long it takes for the activity level of your infused factor to drop by 50%. A longer half-life means that the drug is active in your body for a longer time.
The recommended dosing range is:
In clinical trials, the median dose was:
Low doses may mean less volume per dose and less time for each infusion.
Reference: 1. Data on file. Available from CSL Behring as DOF AFS-001.
Medimop Medical Projects Ltd. is the copyright owner of the Mix2Vial® Video.
Mix2Vial® is a registered trademark of Medimop Projects Ltd.